Morphological change in Pseudomonas aeruginosa following antibiotic treatment of experimental infection in mice and its relation to susceptibility to phagocytosis and to release of endotoxin.
作者信息
Yokochi T, Narita K, Morikawa A, Takahashi K, Kato Y, Sugiyama T, Koide N, Kawai M, Fukada M, Yoshida T
机构信息
Department of Microbiology and Immunology and Division of Bacterial Toxin, Research Center for Infectious Disease, Aichi Medical University, Nagakute, Aichi 480-1195, Japan.
出版信息
Antimicrob Agents Chemother. 2000 Jan;44(1):205-6. doi: 10.1128/AAC.44.1.205-206.2000.
Abstract
The relationship between morphological changes in Pseudomonas aeruginosa following antibiotic treatment of experimental infection in mice, susceptibility to phagocytosis, and release of endotoxin was studied. The intraperitoneal administration of P. aeruginosa with imipenem or ceftazidime into mice induced morphological changes in the cells 2 h after injection. Round P. aeruginosa cells with imipenem treatment became susceptible to phagocytosis by peritoneal cells, whereas long filamentous cells with ceftazidime treatment were hardly phagocytized by peritoneal cells. The morphological changes also affected the plasma endotoxin level in the circulation.
摘要
相似文献
1
Morphological change in Pseudomonas aeruginosa following antibiotic treatment of experimental infection in mice and its relation to susceptibility to phagocytosis and to release of endotoxin.
Antimicrob Agents Chemother. 2000 Jan;44(1):205-6. doi: 10.1128/AAC.44.1.205-206.2000.
2
Quantitative variations in beta-lactam antibiotic released endotoxin from Pseudomonas aeruginosa: in-vivo relevance.
Prog Clin Biol Res. 1995;392:235-51.
3
Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
J Antimicrob Chemother. 2007 May;59(5):926-33. doi: 10.1093/jac/dkm073. Epub 2007 Mar 29.
4
Antibacterial activity of meropenem against Pseudomonas aeruginosa, including antibiotic-induced morphological changes and endotoxin-liberating effects.
Eur J Clin Microbiol Infect Dis. 1998 Nov;17(11):754-60. doi: 10.1007/s100960050180.
5
Relationship between morphological changes and endotoxin release induced by carbapenems in Pseudomonas aeruginosa.
J Med Microbiol. 1999 Mar;48(3):309-315. doi: 10.1099/00222615-48-3-309.
6
Antimicrobial-induced release of endotoxin from Pseudomonas aeruginosa: comparison of in vitro and animal models.
J Antimicrob Chemother. 2003 Feb;51(2):353-9. doi: 10.1093/jac/dkg042.
7
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome.
Microb Drug Resist. 2011 Jun;17(2):305-12. doi: 10.1089/mdr.2010.0170. Epub 2011 Mar 7.
8
Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.00054-17. Print 2017 Jun.
9
An in-vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of gram-negative bacilli.
J Antimicrob Chemother. 1998 Apr;41(4):435-42. doi: 10.1093/jac/41.4.435.
10
In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
J Int Med Res. 2015 Apr;43(2):217-25. doi: 10.1177/0300060514553490. Epub 2014 Dec 29.
引用本文的文献
1
Treatment of Bacterial Infections with β-Lactams: Cooperation with Innate Immunity.
Infect Immun. 2023 Feb 16;91(2):e0050322. doi: 10.1128/iai.00503-22. Epub 2023 Jan 25.
2
Clinical Impact of Antibiotics for the Treatment of Biofilm Infections.
Front Microbiol. 2020 Jan 9;10:2894. doi: 10.3389/fmicb.2019.02894. eCollection 2019.
3
The influence of P. fluorescens cell morphology on the lytic performance and production of phage φIBB-PF7A.
Curr Microbiol. 2011 Oct;63(4):347-53. doi: 10.1007/s00284-011-9987-0. Epub 2011 Jul 26.
4
Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method.
Antimicrob Agents Chemother. 2002 Jul;46(7):2077-86. doi: 10.1128/AAC.46.7.2077-2086.2002.
5
Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.
Clin Microbiol Rev. 2002 Jan;15(1):95-110. doi: 10.1128/CMR.15.1.95-110.2002.
本文引用的文献
1
Low-level release of Shiga-like toxin (verocytotoxin) and endotoxin from enterohemorrhagic Escherichia coli treated with imipenem.
Antimicrob Agents Chemother. 1997 Oct;41(10):2295-6. doi: 10.1128/AAC.41.10.2295.
2
Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide.
Antimicrob Agents Chemother. 1996 Oct;40(10):2410-2. doi: 10.1128/AAC.40.10.2410.
3
Effect of antibiotics on endotoxin release from gram-negative bacteria.
Diagn Microbiol Infect Dis. 1993 Mar-Apr;16(3):185-9. doi: 10.1016/0732-8893(93)90109-k.
4
Clinical relevance of antibiotic-induced endotoxin release.
Antimicrob Agents Chemother. 1994 Jun;38(6):1211-8. doi: 10.1128/AAC.38.6.1211.
5
Antibiotic-induced release of endotoxin. A therapeutic paradox.
Drug Saf. 1995 Mar;12(3):183-95. doi: 10.2165/00002018-199512030-00004.
6
beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime.
J Infect Dis. 1992 Jun;165(6):1033-41. doi: 10.1093/infdis/165.6.1033.
7
Antibiotic-induced release of endotoxin: a reappraisal.
Clin Infect Dis. 1992 Nov;15(5):840-54. doi: 10.1093/clind/15.5.840.
Zotero 插件